# Clinical Trial of CNS-targeted HAART (CIT2)

> **NCT00624195** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 59 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** FDA Approved Antiretroviral Therapy (see list below)

## Key facts

- **NCT ID:** NCT00624195
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624195, "Clinical Trial of CNS-targeted HAART (CIT2)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00624195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*